June 13, 2025

Weight Loss Drugs Show Promise for Heart Failure

ACC statement highlights semaglutide and tirzepatide as therapies associated with improved symptoms and functional capacity in patients with heart failure with preserved ejection fraction and obesity.

Conexiant

June 13, 2025

Lifestyle Interventions Recommended First-Line in Diabetes

A new guideline recommends using lifestyle interventions as first-line treatment to prevent, manage, and potentially reverse type 2 diabetes and prediabetes, supported by extensive clinical evidence.

Conexiant

June 12, 2025

Vegetarian Diet Linked to Lower Cancer Incidence

A large North American cohort study found that vegetarian diets were associated with lower risks of several site-specific cancers, including colorectal, stomach, breast, prostate, and lymphoproliferative cancers.

Conexiant

June 12, 2025

What's the Best Scoring Method in CRC Prognosis?

Study of three systems finds that a simple tumor growth pattern scoring method independently predicts colon cancer–specific survival.

The Pathologist

June 11, 2025

Simvastatin Lowers Cholesterol—but Does Not Improve Depression Symptoms

A randomized trial of 160 adults with depression and obesity found no improvement in mood symptoms from adding simvastatin to escitalopram, though the statin significantly lowered cholesterol and inflammation levels.

Conexiant

June 10, 2025

Everolimus Plus Lanreotide vs Everolimus Alone in Aggressive Gastroenteropancreatic Neuroendocrine Tumors

In patients with aggressive gastroenteropancreatic neuroendocrine tumors, first-line treatment with the mTOR inhibitor everolimus and the somatostatin analog lanreotide more than doubled the median pr...

The ASCO Post

June 10, 2025

Heavy Drinking Ups Pancreatic Cancer Risk, Large Study Finds

Each 10-g increase in daily alcohol intake was linked to a 3% rise in risk.

Conexiant

June 10, 2025

Can Gallbladder Surgery Cut Risk and Costs?

A national study of older adults with multimorbidity found that surgery for acute cholecystitis reduced readmissions, emergency visits, and long-term costs compared to non-operative treatment.

Conexiant

June 10, 2025

Gastric Bypass Lowers Cardiac Risk Long Term

Over 39,000 patients were followed for up to 11 years in a large national study comparing major heart event risks after gastric bypass and sleeve gastrectomy.

Conexiant